Keyphrases
Confidence Interval
81%
Polymorphism
65%
Lung Cancer
62%
Pooled Analysis
50%
Odds Ratio
44%
Meta-analysis
43%
Genotype
34%
Non-small Cell Lung Cancer (NSCLC)
33%
Hurricane Sandy
31%
Cytochrome P450 1A1 (CYP1A1)
30%
Prostate Cancer
28%
Mesothelioma
27%
GSTM1
27%
Malignant Pleural Mesothelioma
27%
Breast Cancer
25%
Early-stage Lung Cancer
24%
Genetic Susceptibility
24%
Lung Cancer Risk
23%
Metabolic Genes
23%
Gene Polymorphism
22%
Quality of Life
22%
Black Men
21%
Risk Factors
21%
Lung Cancer Screening
19%
United States
19%
High Risk
19%
GSTT1
19%
Hypertension
19%
New York City
19%
NHANES
19%
Italy
18%
Racial Disparities
18%
African American
18%
Surveillance Epidemiology
18%
DNA Adducts
18%
Lung
17%
Overall Survival
17%
National Health Interview Survey
16%
Environmental Carcinogens
16%
World Trade Center
16%
High-risk Human Papillomavirus (HR-HPV)
15%
Hazard Ratio
15%
Cancer Risk
15%
Breast Cancer Risk
14%
Lung Cancer Patients
14%
COVID-19
14%
Lobectomy
14%
White People
13%
Asbestos
13%
Clinical Characteristics
13%
Medicine and Dentistry
Lung Cancer
100%
Malignant Neoplasm
69%
Non Small Cell Lung Cancer
46%
Odds Ratio
37%
Pooled Analysis
31%
Cancer Risk
28%
Lobectomy
27%
Mesothelioma
27%
Meta-Analysis
27%
Diseases
25%
Prostate Cancer
25%
Pleura Mesothelioma
24%
Breast Cancer
23%
Quality of Life
22%
Biological Marker
21%
Prevalence
20%
Mental Health
19%
Overall Survival
19%
Surveillance, Epidemiology, and End Results
18%
COVID-19
18%
Wart Virus
18%
Cohort Effect
17%
Hazard Ratio
17%
Carcinogen
17%
Lung
17%
Neoplasm
17%
Cytochrome P450 1A1
15%
Medicare
15%
Case-Control Study
15%
Pneumonectomy
15%
Racial Disparity
15%
Genetic Susceptibility
14%
Lung Cancer Screening
14%
National Health and Nutrition Examination Survey
13%
Comorbidity
12%
Cancer
11%
Papillomavirus Infection
11%
Immunotherapy
11%
Cancer Diagnosis
11%
Race Difference
11%
Thyroid Cancer
10%
Video-Assisted Thoracoscopic Surgery
9%
Family History
9%
Tumor
9%
Stereotactic Body Radiation Therapy
9%
Decortication
9%
DNA Polymorphism
9%
Esophageal Cancer
9%
Proportional Hazards Model
9%
Cancer Incidence
9%